About SH2 domain-containing protein 7
SH2 domain-containing protein 7 (SH2D7) is a protein
from Homo sapiens identified by UniProt accession
A6NKC9, 451 residues long.
MolForge cross-references it against 0 known binders and
11 disease associations.
Target properties
| Protein name | SH2 domain-containing protein 7 |
| UniProt accession | A6NKC9 |
| Gene | SH2D7 |
| Organism | Homo sapiens |
| Length | 451 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (11)
Diseases linked to this target (Open Targets).
- calcium measurement · score 0.16
- total blood protein measurement · score 0.15
- serum albumin measurement · score 0.08
- hematocrit · score 0.07
- erythrocyte count · score 0.04
- hemoglobin measurement · score 0.03
- Red cell distribution width · score 0.03
- protein measurement · score 0.02
- diet measurement · score 0.02
- ulcerative colitis · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A6NKC9-F1 | alphafold | PREDICTED | 57.10 | — |
Amino-acid sequence (451 residues)
MEDSLKQLSL GRDPEGAGDS QALAELQELA LKWFMETQAP FILQNGALPP WFHGFITRKQ TEQLLRDKAL GSFLIRLSDR ATGYILSYRG SDRCRHFVIN QLRNRRYIIS GDTQSHSTLA ELVHHYQEAQ LEPFKEMLTA ACPRPEDNDL YDAITRGLHQ TIVDPENPPA TAFLTVVPDK AASPRSSPKP QVSFLHAQKS LDVSPRNLSQ EESMEAPIRV SPLPEKSSSL LEESFGGPSD IIYADLRRMN QARLGLGTEG SGRHGPVPAG SQAYSPGREA QRRLSDGEQN RPDGLGPVLS GVSPDQGPTE SPTSWGCSDA MGSLGATWRQ EFPKLSQEAQ PCSQGSSADI YEFIGTEGLL QEARDTPDQE GSTYEQIPAC WGGPARAPHP GASPTYSPWV HGYKRISGTP ELSEPGNTYE QIPATKSKET GRTHKPDKLR RLFFTYRKHK F
Explore SH2 domain-containing protein 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets